Prevalence and clinical significance of antibodies directed against protein S in patients with systemic lupus erythematosus.

被引:0
|
作者
Ralhan, S
Bertolaccini, ML
Khamashta, MA
Merrill, JT
Hughes, GRV
机构
来源
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1323
引用
收藏
页码:S273 / S273
页数:1
相关论文
共 50 条
  • [1] Prevalence, clinical significance and characteristics of antibodies to protein S in patients with systemic lupus erythematosus.
    Bertolaccini, ML
    Gennari, LC
    Ralham, S
    Khamashta, MA
    Hughes, GRV
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S48 - S49
  • [2] Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance
    Bertolaccini, ML
    Sanna, G
    Ralhan, S
    Gennari, LC
    Merrill, JT
    Khamashta, MA
    Hughes, GRV
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) : 636 - 641
  • [3] Clinical significance of anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Molina, JF
    Gomez, JA
    Bedoya, AM
    Anaya, JM
    Molina, J
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S247 - S247
  • [4] Antiprothrombin antibodies: Detection, immunological characteristics and clinical significance in patients with systemic lupus erythematosus.
    Bertolaccini, ML
    Atstumi, T
    Khamashta, MA
    Koike, T
    Hughes, GRV
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S218 - S218
  • [5] Prevalence and clinical characteristics of cryoglobulinemia in patients with systemic lupus erythematosus.
    Garcia-Carrasco, M
    Cervera, R
    Trejo, O
    Ramos-Casals, M
    Yague, J
    Siso, A
    Jimenez, S
    de la Red, G
    Font, J
    Ingelmo, M
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S255 - S255
  • [6] Antiprothrombin antibodies detected in two different assay systems: Prevalence and clinical significance in systemic lupus erythematosus.
    Bertolaccini, ML
    Atsumi, T
    Koike, T
    Hughes, GRV
    Khamashta, MA
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S73 - S73
  • [7] Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
    Font, J
    Muñoz-Rodriguez, FJ
    Reverter, JC
    Tassies, D
    Espinosa, G
    Cervera, R
    Ingelmo, M
    Ordinas, A
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S278 - S278
  • [8] Clinical significance of antiphospholipid nephropathy in systemic lupus erythematosus.
    Jara, LJ
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S383 - S384
  • [9] Prevalence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia
    Wang, CL
    Ooi, L
    Wang, F
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (02): : 129 - 132
  • [10] Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus.
    Campos, LMA
    Kiss, MHB
    Scheinberg, MA
    Mangueira, CLP
    Silva, CA
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S302 - S302